Volume | 3,680,748 |
|
|||||
News | - | ||||||
Day High | 0.11 | Low High |
|||||
Day Low | 0.093 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Akanda Corporation | AKAN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.093 | 0.093 | 0.11 | 0.0941 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3,029 | 3,680,748 | US$ 0.0988179 | US$ 363,724 | - | 0.0911 - 2.70 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:32:58 | 900 | US$ 0.094 | USD |
Akanda Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
349.2k | 3.88M | - | 3.87M | -11.66M | -3.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Akanda News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKAN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1775 | 0.188 | 0.0911 | 0.1248668 | 9,611,336 | -0.0835 | -47.04% |
1 Month | 0.225 | 0.27 | 0.0911 | 0.1312738 | 11,482,510 | -0.131 | -58.22% |
3 Months | 0.41 | 0.71 | 0.0911 | 0.1565512 | 4,486,290 | -0.316 | -77.07% |
6 Months | 0.516 | 0.71 | 0.0911 | 0.1616973 | 2,118,275 | -0.422 | -81.78% |
1 Year | 1.24 | 2.70 | 0.0911 | 0.3650961 | 1,368,123 | -1.15 | -92.42% |
3 Years | 300.00 | 310.00 | 0.0911 | 5.13 | 1,818,308 | -299.91 | -99.97% |
5 Years | 300.00 | 310.00 | 0.0911 | 5.13 | 1,818,308 | -299.91 | -99.97% |
Akanda Description
Akanda Corp is an international medical cannabis company cultivating cannabis of the highest quality at scale, leveraging trusted brands, at a low-cost compared to many of its competitors. The company is building a seed-to-patient supply chain, connecting patients in the UK and Europe with diverse products including cannabis products cultivated at its competitively advantaged grow operation in the Kingdom of Lesotho and with other trusted third-party brands. |